Winton Capital »

Monte Rosa Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $360k 23k 15.68

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Intel Corporation (INTC)
Devon Energy Corporation (DVN)
Solstice Advanced Matls Com Shs (SOLS)
Epam Systems (EPAM)
Chart Industries (GTLS)
Hologic (HOLX)
Electronic Arts (EA)
Ceridian Hcm Hldg
Masco Corporation (MAS)
Boeing Company (BA)
Five Below (FIVE)

View all positions for Winton Capital

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics